India produces over 30% of the world’s entire supply of generic drugs. Cipla is one of India’s largest drug manufacturers. It supplies antiretroviral drugs to about one third of AIDS patients under treatment in Africa. C&EN Senior Correspondent Jean-François Tremblay went inside Cipla’s advanced pharmaceutical ingredient manufacturing plant to learn more about the stringent regulations it must follow. India’s future as the world’s drugstore is a controversial topic. Other drugmakers have been heavily fined, or had products recalled or banned, because of problems at plants. And India is under pressure to make its patent system more like those in western nations. But India has found a market for low-cost drugs and that market isn’t about to disappear.
Like C&EN? Want more chemistry video goodness? Subscribe to our YouTube channel:
Subscribe to C&EN to watch science videos with a focus on chemistry, and to hear from the researchers behind it all.